Welcome to LookChem.com Sign In|Join Free

CAS

  • or

862723-42-0

Post Buying Request

862723-42-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

862723-42-0 Usage

General Description

Indazole-5-boronic acid pinacol ester is a chemical compound that belongs to the class of boronic acid esters. It is a derivative of indazole, a heterocyclic aromatic organic compound. INDAZOLE-5-BORONIC ACID PINACOL ESTER has been studied for its potential applications in medicinal chemistry, particularly as a building block for the synthesis of pharmaceutical compounds. It has also been investigated for its potential use in various catalytic processes. Indazole-5-boronic acid pinacol ester is a valuable tool for chemists and researchers working in the fields of drug discovery, organic synthesis, and catalysis. Its unique structure and reactivity make it a promising candidate for the development of new chemical and pharmaceutical products.

Check Digit Verification of cas no

The CAS Registry Mumber 862723-42-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,2,7,2 and 3 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 862723-42:
(8*8)+(7*6)+(6*2)+(5*7)+(4*2)+(3*3)+(2*4)+(1*2)=180
180 % 10 = 0
So 862723-42-0 is a valid CAS Registry Number.
InChI:InChI=1/C13H17BN2O2/c1-12(2)13(3,4)18-14(17-12)10-5-6-11-9(7-10)8-15-16-11/h5-8H,1-4H3,(H,15,16)

862723-42-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (692727)  1H-Indazole-5-boronicacidpinacolester  95%

  • 862723-42-0

  • 692727-1G

  • 1,977.30CNY

  • Detail
  • Aldrich

  • (692727)  1H-Indazole-5-boronicacidpinacolester  95%

  • 862723-42-0

  • 692727-5G

  • 6,897.15CNY

  • Detail

862723-42-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole

1.2 Other means of identification

Product number -
Other names 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:862723-42-0 SDS

862723-42-0Relevant articles and documents

IMIDAZO[1,2-A]PYRAZINE MODULATORS OF THE ADENOSINE A2A RECEPTOR

-

Page/Page column 78, (2019/01/17)

The present invention relates to the compound of formula (I) and salts, stereoisomers, tautomers, isotopologues,or N-oxides thereof. The present invention is further concerned with the use of such a compound or salt, stereoisomer, tautomer, isotopologues,or N-oxide thereof as medicament and a pharmaceutical composition comprising said compound.

Heterocyclic compound with Wnt signal path inhibitory activity and application thereof

-

Paragraph 0125; 0126; 0127, (2016/10/08)

The invention provides a heterocyclic compound with Wnt signal path inhibitory activity. The heterocyclic compound and chemically acceptable salt, isotope, isomer and a crystal structure thereof are provided with a structure shown as the general formula I (see the formula in the description). The invention further provides application of the heterocyclic compound with the Wnt signal path inhibitory activity. The heterocyclic compound with the Wnt signal path inhibitory activity serves as effective antagonist of a Wnt signal path, and can be used for treating or preventing diseases caused by abnormity of the Wnt signal path.

HEPARAN SULFATE BIOSYNTHESIS INHIBITORS FOR THE TREATMENT OF DISEASES

-

Paragraph 000170; 000184; 000196, (2016/05/02)

Described herein are compounds of Formula I, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or conditions in need of inhibition of heparan sulfate biosynthesis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 862723-42-0